Thursday, November 21, 2024
11/21/2024
Project Summary Fragile X Syndrome (FXS), a rare monogenic neurodevelopmental disorder caused by a trinucleotide expansion of the Fmr1 gene on the X chromosome. FXS is the most common inherited form of intellectual disability (ID) and monogenic cause of autism spectrum disorder (ASD), characterized by sensory hypersensitivities, executive dysfunction, learning difficulties, and social anxiety. Individuals with FXS also exhibit increased functional connectivity (FC) abnormalities observed using electroencephalography (EEG) related to cognitive impairments and behavioral features of FXS, with a high degree of heterogeneity (despite being monogenic). Limited work has addressed these FC disruptions in frontoparietal, and temporal networks with no studies directly assessing FC disruptions during a cognitive task. I hypothesize specific network connectivity dynamics within frontoparietal and temporal regions in FXS will effectively parse higher-order behavioral features of FXS from ID, with frontoparietal FC disruption related to the “control network” being more associated with both ID and cognitive control (including cognitive/behavioral flexibility) and temporal “salience network” FC more associated with other FXS features, particularly sensory hypersensitivity and anxiety. The long-term goal of this proposal is to characterize functional disruptions in networks underlying ID and cognitive function as separate from behavioral features of FXS to identify targets for intervention while using a cognitive task and address heterogeneity in neural network performance underlying features core to FXS (e.g., hyperactivity, sensory processing difficulties, anxiety). Experiments proposed in Aim 1 will use robust FC measures through a source analysis to parse ID from other features of FXS to evaluate the effectiveness of using microstates as a proxy and to explore the triple network hypothesis in FXS by assessing FC during a cognitive task. Aim 2 will utilize data-driven methods to identify variable combinations from EEG to meaningfully distinguishing FXS from individuals with developmental delay (DD), and parse cognitive ability/ID (defined by NIH Toolbox for ID and nonverbal IQ) from other FXS features (i.e., anxiety, hyperactivity, sensory hypersensitivities). The proposed project will have broad implications for ongoing efforts to evaluate neurophysiology in FXS and the development of effective biomarkers for therapeutic applications, particularly taking the novel approach of addressing FC during a cognitive task.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
